Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

A meta-analysis analyzing the efficacy and safety of datopotamab deruxtecan (Dato-DXd) in previously treated patients with non-small cell lung cancer (NSCLC). SVs in targetable genes CH SVs in WBC, ...

US-based manufacturer SVS has added two subwoofers to its range, promising they will offer "reference low frequency performance" for home cinema and music fans. The SB-5000 and the PB-5000 R|Evolution ...

INCHEON, Korea--(BUSINESS WIRE)--Samsung Bioepis Co., Ltd. today announced that the U.S. Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for OSPOMYV™ (denosumab ...

INCHEON, Korea--(BUSINESS WIRE)--Samsung Bioepis Co., Ltd. today announced that the European Commission (EC) has granted marketing authorization for OBODENCE™ (60mg pre-filled syringe) and XBRYK™ ...

INCHEON, Korea, May 27, 2024 (GLOBE NEWSWIRE) -- Samsung Bioepis Co., Ltd. today presented follow-up results from Phase 3 study on SB16, a proposed biosimilar to Prolia 1 (denosumab) as oral ...

2023 was an exciting year to cover all things tech! Here is our year in review with the top 10 stories our readers loved. In the realm of audio excellence, few components are as pivotal as the ...

In the realm of audio excellence, few components are as pivotal as the subwoofer. The heart-pounding, low-frequency vibrations from a high-quality subwoofer can transform any audio experience into an ...

INCHEON, Korea, Oct. 15, 2023 (GLOBE NEWSWIRE) -- Samsung Bioepis Co., Ltd. today presented two clinical study data for SB16, a proposed biosimilar to Prolia (denosumab), at the American Society for ...